NCT01603238View on ClinicalTrials.gov

Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C] LC15-0444

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

May 31, 2011

Study Completion Date

July 31, 2011

Conditions

Healthy

Interventions

DRUG

[14C]-LC15-0444

A single oral administration of \[14C\]-LC15-0444 50 mg, containing 4.9 MBq \[14C\]. Subjects in the fasted state will receive the drug as a capsule, with 240 ml of water.

Trial Locations (1)

110-062

LG Life Sciences, Seoul